Futura medical’s profit warning leave s nagging doubts so exit now

Shares in Latin American ecommerce and digital finance firm have soared although long-term investors may want to stick rather than twist

WHO IS WINNING BETWEEN NOVO-NORDISK AND ELI LILLY?

A whistle-stop tour of new faces, farewells, winners and losers

Renamed and under new management, this trust offers exposure to attractively-valued market leaders with pricing power

Tariffs, Trump and volatile stock market performance blight our picks

The Panadol-to-Sensodyne supplier’s pricing power and structural growth opportunity remain mispriced